Why Staar Surgical Stock Soared Today

STAA surged 7.5% Friday after announcing a $50 million share buyback program authorized by its board. CEO Caren Mason cited the company's strong balance sheet, ample free cash flow, and a view that the stock is substantially undervalued as drivers behind the authorization.

The buyback comes on the heels of strong second-quarter fundamentals. STAA more than doubled net sales year-over-year in Q2, with China driving a significant portion of the growth. The company turned profitable during the quarter and held nearly $149 million in cash on its balance sheet, providing the financial flexibility to return capital to shareholders while maintaining operational momentum.

The authorization signals management's confidence in the business trajectory and its willingness to deploy capital opportunistically. With the stock trading below management's internal valuation and cash reserves healthy, the buyback serves as both a capital allocation decision and a bullish statement on STAA's prospects.